NCT05741294 2025-02-20
A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses
Almirall, S.A.
Phase 4 Completed
Clinical Trials
9 trialsNCT04055142 2024-07-10
TreatAIN
Hospital Universitari Vall d'Hebron Research Institute
Phase 3 Completed
NCT04541290 2022-02-09
Tacrolimus as Treatment of Breast Cancer-Related Lymphedema
Odense University Hospital
Phase 1/2 Completed
NCT03380026 2021-11-24
MIDAS
Rochester Skin Lymphoma Medical Group, PLLC
Phase 2 Completed
NCT03083470 2019-05-15
Study of SOR007 Ointment for Actinic Keratosis
DFB Soria, LLC
Phase 2 Completed
NCT02019355 2016-05-19
AK
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT02587819 2016-04-14
Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment
Biosceptre
Phase 1 Completed
NCT01593995 2014-11-04
EGF Ointment for Erlotinib Skin Lesion
Dong-A University Hospital
Phase 2 Completed
NCT01082302 2010-09-08
Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage
MediGene
Phase 4 Completed